Challenges in Answering Safety Questions and Developing Recommendations for Checkpoint Inhibitor Treatment in PSA Patients

The speakers discuss the difficulties of addressing safety concerns in PSA patients undergoing checkpoint inhibitor treatment and describe their approach to summarizing evidence and developing recommendations using the Delphi process.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app